Immediate Impact
54 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Works of Gabriel Cea being referenced
Clinical and epidemiological features of myasthenia gravis in Chilean population
2018
Thymectomy for non-thymomatous myasthenia gravis
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gabriel Cea | 446 | 75 | 123 | 223 | 187 | 23 | 822 | |
| Sandford Jaques | 158 | 68 | 206 | 90 | 181 | 17 | 669 | |
| Jie Luo | 242 | 10 | 119 | 190 | 49 | 33 | 677 | |
| R S Kocen | 299 | 218 | 125 | 118 | 40 | 26 | 853 | |
| Sertaç İşlekel | 192 | 68 | 50 | 114 | 192 | 23 | 677 | |
| Anthony C. Breuer | 249 | 136 | 139 | 261 | 68 | 21 | 817 | |
| Stephen N. Scelsa | 472 | 115 | 143 | 50 | 35 | 33 | 720 | |
| Peter J. Spaeth | 142 | 39 | 96 | 107 | 59 | 24 | 775 | |
| H A Homburger | 203 | 54 | 149 | 94 | 77 | 31 | 872 | |
| R. Monforte | 277 | 105 | 70 | 72 | 42 | 31 | 663 | |
| Jonathan Noonan | 85 | 29 | 182 | 66 | 225 | 32 | 926 |
All Works
Login with ORCID to disown or claim papers
Loading papers...